Description

Biosimilars: policy, insurance and implications for cancer patients
StatusActive
Effective start/end date1/1/1812/31/21

Funding

  • AMERICAN CANCER SOCIETY, INC.

Fingerprint

Biosimilar Pharmaceuticals
Insurance
Neoplasms